Post-Craniotomy Pain Management: Beyond Opioids

被引:52
作者
Dunn, Lauren K. [1 ]
Naik, Bhiken I. [1 ,2 ]
Nemergut, Edward C. [1 ,2 ]
Durieux, Marcel E. [1 ,2 ]
机构
[1] Univ Virginia, Dept Anesthesiol, POB 800710, Charlottesville, VA 22908 USA
[2] Univ Virginia, Dept Neurosurg, POB 800710, Charlottesville, VA 22908 USA
关键词
Craniotomy; Pain; Post-operative; Analgesia; Neurosurgery; POSTOPERATIVE PAIN; SCALP INFILTRATION; DOUBLE-BLIND; POSTCRANIOTOMY PAIN; INTRAOPERATIVE DEXMEDETOMIDINE; TRANSITIONAL ANALGESIA; REMIFENTANIL; MORPHINE; BUPIVACAINE; FENTANYL;
D O I
10.1007/s11910-016-0693-y
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Craniotomy pain may be severe and is often undertreated. Pain management following craniotomy is a balancing act of achieving adequate analgesia but avoiding sedation, respiratory depression, hypercapnia, nausea and vomiting, and hypertension. Opioids are a first-line analgesic therapy; however, concern that opioid-related adverse effects (sedation, respiratory depression) may interfere with neurologic assessment and increase intracranial pressure has limited use of these drugs for intracranial surgery. Non-opioid analgesics avoid these effects and may be useful as part of a multimodal regimen for post-craniotomy pain. Regional scalp blocks, paracetamol, and non-steroidal anti-inflammatory drugs are beneficial in the early post-operative period. Recent studies suggest a role for novel analgesics: dexmedetomidine, gabapentinoids, and ketamine, though additional studies are necessary.
引用
收藏
页数:10
相关论文
共 56 条